The Pharmagellan Guide to Biotech Forecasting and Valuation (099840750X)

If you're a biotech executive, investor, deal maker, entrepreneur, or adviser--or aspire to be one--then you need to know how to build and analyze forecasts and valuation models of R&D-stage drugs.

THE PHARMAGELLAN GUIDE TO BIOTECH FORECASTING AND VALUATION is a comprehensive, thoroughly referenced handbook to creating and interpreting financial models for early-stage biopharma assets and companies.

- Vetted benchmarks for key drivers of income, expenses, and valuation.
- Proprietary analyses by Pharmagellan's experienced consulting team.
- More than 150 current references from peer-reviewed research, industry white papers, and SEC filings.

Whether you're making investment decisions, pitching to potential partners or funders, or assessing your own R&D program, this is the one-stop guide you need by your side.

Product details

• Format Paperback | 138 pages
• Dimensions 152 x 229 x 8mm | 213g
• Publication date 06 Jan 2017
• Publisher Pharmagellan, LLC
• Language English
• ISBN10 099840750X
• ISBN13 9780998407500

Download The Pharmagellan Guide to Biotech Forecasting and Valuation (099840750X).pdf, available at ebookdownloadfree.co for free.

>DOWNLOAD NOW<